Senestech (NASDAQ:SNES – Get Free Report) is expected to be issuing its Q4 2025 results before the market opens on Wednesday, March 11th. Analysts expect the company to announce earnings of ($0.30) per share and revenue of $0.7760 million for the quarter. Investors can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Thursday, March 19, 2026 at 4:00 PM ET.
Senestech Price Performance
Shares of NASDAQ:SNES opened at $2.17 on Monday. The company has a market capitalization of $11.33 million, a P/E ratio of -0.59 and a beta of 0.14. The company’s 50-day moving average is $2.09 and its 200 day moving average is $3.11. The company has a debt-to-equity ratio of 0.01, a quick ratio of 14.73 and a current ratio of 15.75. Senestech has a fifty-two week low of $1.30 and a fifty-two week high of $6.24.
Insider Transactions at Senestech
In other news, major shareholder Glenbrook Capital Management bought 34,613 shares of the firm’s stock in a transaction on Thursday, February 19th. The stock was acquired at an average cost of $2.40 per share, with a total value of $83,071.20. Following the completion of the transaction, the insider directly owned 704,211 shares of the company’s stock, valued at $1,690,106.40. This represents a 5.17% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders acquired 173,954 shares of company stock valued at $367,303 over the last three months. Company insiders own 5.29% of the company’s stock.
Institutional Inflows and Outflows
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Senestech in a research report on Monday, December 29th. One analyst has rated the stock with a Strong Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold”.
Check Out Our Latest Report on Senestech
Senestech Company Profile
SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.
The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.
Recommended Stories
- Five stocks we like better than Senestech
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Senestech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senestech and related companies with MarketBeat.com's FREE daily email newsletter.
